What is the evidence for anti-TNF biosimilars in rheumatoid arthritis?

Chapter 1: What is the evidence for anti-TNF biosimilars in rheumatoid arthritis? (0:00)

Chapter 2: Are there any clinical benefits from use of biosimilars versus their reference biologics? (5:32)

Chapter 3: Is there a difference in the amount of clinical evidence required for anti-TNF biosimilar approvals across indications? (7:12)